Differences in emotion recognition between nonimmersive versus immersive virtual reality: preliminary findings in schizophrenia and bipolar disorder
Deficits in social cognition may impair emotional processing and facial emotional recognition (FER) in patients with bipolar disorder (BD) and schizophrenia. FER is generally explored using photographs or images of static faces that do not fully capture the complexity of real-life facial stimuli. To overcome this limitation, we developed a set of dynamic virtual faces depicting six basic emotions (i.e. happiness, sadness, anger, fear, disgust, and surprise) and a neutral expression suitable for presentation in immersive and nonimmersive virtual realities. This study presents preliminary findings on the differences in FER accuracy from a frontal view between immersive and nonimmersive virtual realities among patients experiencing a relapse of schizophrenia ( n = 10), a manic phase of BD ( n = 10), and a group of healthy controls (HCs) ( n = 10). As a secondary objective, we compare the FER accuracy across these three groups. Patients with schizophrenia and BD showed similar accuracy in recognizing emotions in immersive and nonimmersive virtual reality settings. However, patients with schizophrenia exhibited lower FER accuracy than HCs in both settings. Individuals with BD showed intermediate accuracy between those with schizophrenia and HCs, although these differences were not statistically significant. Notably, recognition of negative emotions was significantly impaired in both groups of patients.
Authors
- Giuseppe Fanelli (ORCID: https://orcid.org/0000-0001-7930-563X)
- Chiara Fabbri (ORCID: https://orcid.org/0000-0003-0276-7865)
- Verónica Romero‐Ferreiro (ORCID: https://orcid.org/0000-0003-3211-1744)
- Miguel Ángel Álvarez-Mon (ORCID: https://orcid.org/0000-0002-1987-0394)
- Antonio Fernández‐Caballero (ORCID: https://orcid.org/0000-0002-8211-0398)
- Guillermo Lahera (ORCID: https://orcid.org/0000-0002-6152-3564)
- Alessandro Serretti (ORCID: https://orcid.org/0000-0003-4363-3759)
- Daniel Sánchez-Reolid (ORCID: https://orcid.org/0000-0003-3612-1261)
- Roberto Sánchez-Reolid (ORCID: https://orcid.org/0000-0003-4455-370X)
- Patricia Fernández-Sotos
- Mauro Scala
- Roberto Rodriguez-Jimenez
Institutions
- Universidad Complutense de Madrid (ES)
- Radboud University Nijmegen (NL)
- Universidad de Alcalá (ES)
- Instituto Cajal (ES)
- Università degli Studi di Enna Kore (IT)
- Radboud University Medical Center (NL)
- Research Institute Hospital 12 de Octubre (ES)
- Oasi Maria SS (IT)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Medical Research Network (US)
- Hospital Universitario Infanta Leonor (ES)
- University of Castilla-La Mancha (ES)
- Universidad Europea de Madrid (ES)
- University of Bologna (IT)
Publication Details
- Journal
- International Clinical Psychopharmacology
- Published
- 2024-12-06
- DOI
- https://doi.org/10.1097/yic.0000000000000576
- Citations
- 3
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16